Down-Regulation of HBXIP Inhibits Non-Small Cell Lung Cancer Growth and Enhances the Anti-Tumor Immunity of Mice by Reducing NRP-1
CONCLUSION: Down-regulation of HBXIP reduced Lin28B-mediated NRP-1 to suppress NSCLC cell growth and enhance anti-tumor immunity.PMID:34452886
Source: Annals of Clinical and Laboratory Science - Category: Laboratory Medicine Authors: Lulu Wang Mao Sun Xing Lin Yongyang Lei Zhe Yin Wei Zhou Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Epithelial Cancer | Hepatitis | Hepatitis B | Laboratory Medicine | Lung Cancer | Neurology | Neuroscience | Non-Small Cell Lung Cancer | Science